nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Dyspnoea—Mitoxantrone—sarcoma	0.00191	0.00191	CcSEcCtD
Fosaprepitant—Cough—Etoposide—sarcoma	0.00191	0.00191	CcSEcCtD
Fosaprepitant—Somnolence—Mitoxantrone—sarcoma	0.0019	0.0019	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Vincristine—sarcoma	0.0019	0.0019	CcSEcCtD
Fosaprepitant—Fatigue—Vincristine—sarcoma	0.0019	0.0019	CcSEcCtD
Fosaprepitant—Hyponatraemia—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Fosaprepitant—Dyspepsia—Mitoxantrone—sarcoma	0.00189	0.00189	CcSEcCtD
Fosaprepitant—Hypertension—Etoposide—sarcoma	0.00189	0.00189	CcSEcCtD
Fosaprepitant—Pain—Vincristine—sarcoma	0.00188	0.00188	CcSEcCtD
Fosaprepitant—Constipation—Vincristine—sarcoma	0.00188	0.00188	CcSEcCtD
Fosaprepitant—Osteoarthritis—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Fosaprepitant—Decreased appetite—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Fosaprepitant—Chest pain—Etoposide—sarcoma	0.00186	0.00186	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Fosaprepitant—Hypokalaemia—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Fosaprepitant—Fatigue—Mitoxantrone—sarcoma	0.00185	0.00185	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Fosaprepitant—Discomfort—Etoposide—sarcoma	0.00184	0.00184	CcSEcCtD
Fosaprepitant—Constipation—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Fosaprepitant—Pain—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Fosaprepitant—Hypersensitivity—Thiotepa—sarcoma	0.00183	0.00183	CcSEcCtD
Fosaprepitant—Hypersensitivity—Dactinomycin—sarcoma	0.00181	0.00181	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Vincristine—sarcoma	0.0018	0.0018	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Fosaprepitant—Muscular weakness—Epirubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Fosaprepitant—Asthenia—Thiotepa—sarcoma	0.00178	0.00178	CcSEcCtD
Fosaprepitant—Infection—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Fosaprepitant—Abdominal distension—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Fosaprepitant—Asthenia—Dactinomycin—sarcoma	0.00177	0.00177	CcSEcCtD
Fosaprepitant—Feeling abnormal—Mitoxantrone—sarcoma	0.00177	0.00177	CcSEcCtD
Fosaprepitant—Pruritus—Thiotepa—sarcoma	0.00176	0.00176	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00175	0.00175	CcSEcCtD
Fosaprepitant—Abdominal pain—Vincristine—sarcoma	0.00174	0.00174	CcSEcCtD
Fosaprepitant—Body temperature increased—Vincristine—sarcoma	0.00174	0.00174	CcSEcCtD
Fosaprepitant—Skin disorder—Etoposide—sarcoma	0.00173	0.00173	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Fosaprepitant—Hypokalaemia—Doxorubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Fosaprepitant—Urticaria—Mitoxantrone—sarcoma	0.0017	0.0017	CcSEcCtD
Fosaprepitant—Diarrhoea—Thiotepa—sarcoma	0.0017	0.0017	CcSEcCtD
Fosaprepitant—Body temperature increased—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Abdominal pain—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Diarrhoea—Dactinomycin—sarcoma	0.00168	0.00168	CcSEcCtD
Fosaprepitant—Hypotension—Etoposide—sarcoma	0.00167	0.00167	CcSEcCtD
Fosaprepitant—Muscular weakness—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Fosaprepitant—Dysuria—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Fosaprepitant—Dizziness—Thiotepa—sarcoma	0.00164	0.00164	CcSEcCtD
Fosaprepitant—Abdominal distension—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Fosaprepitant—Pollakiuria—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Fosaprepitant—Hypersensitivity—Vincristine—sarcoma	0.00162	0.00162	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Fosaprepitant—Weight decreased—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Fosaprepitant—Dyspnoea—Etoposide—sarcoma	0.00159	0.00159	CcSEcCtD
Fosaprepitant—Somnolence—Etoposide—sarcoma	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Hypersensitivity—Mitoxantrone—sarcoma	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Asthenia—Vincristine—sarcoma	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Vomiting—Thiotepa—sarcoma	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Infestation NOS—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Fosaprepitant—Infestation—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Fosaprepitant—Vomiting—Dactinomycin—sarcoma	0.00157	0.00157	CcSEcCtD
Fosaprepitant—Rash—Thiotepa—sarcoma	0.00156	0.00156	CcSEcCtD
Fosaprepitant—Dermatitis—Thiotepa—sarcoma	0.00156	0.00156	CcSEcCtD
Fosaprepitant—Headache—Thiotepa—sarcoma	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Rash—Dactinomycin—sarcoma	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Decreased appetite—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Etoposide—sarcoma	0.00154	0.00154	CcSEcCtD
Fosaprepitant—Asthenia—Mitoxantrone—sarcoma	0.00154	0.00154	CcSEcCtD
Fosaprepitant—Fatigue—Etoposide—sarcoma	0.00154	0.00154	CcSEcCtD
Fosaprepitant—Stomatitis—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Fosaprepitant—Constipation—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Fosaprepitant—Pain—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Fosaprepitant—Conjunctivitis—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Fosaprepitant—Urinary tract infection—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Fosaprepitant—Dysuria—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Fosaprepitant—Diarrhoea—Vincristine—sarcoma	0.00151	0.00151	CcSEcCtD
Fosaprepitant—Pollakiuria—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Fosaprepitant—Haematuria—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Fosaprepitant—Nausea—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Weight decreased—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Feeling abnormal—Etoposide—sarcoma	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Diarrhoea—Mitoxantrone—sarcoma	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Nausea—Dactinomycin—sarcoma	0.00146	0.00146	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Etoposide—sarcoma	0.00146	0.00146	CcSEcCtD
Fosaprepitant—Dizziness—Vincristine—sarcoma	0.00145	0.00145	CcSEcCtD
Fosaprepitant—Infestation NOS—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Fosaprepitant—Infestation—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Fosaprepitant—Bradycardia—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Fosaprepitant—Urticaria—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Fosaprepitant—Stomatitis—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Abdominal pain—Etoposide—sarcoma	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Body temperature increased—Etoposide—sarcoma	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Conjunctivitis—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Urinary tract infection—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Fosaprepitant—Vomiting—Vincristine—sarcoma	0.0014	0.0014	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Rash—Vincristine—sarcoma	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Dermatitis—Vincristine—sarcoma	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Haematuria—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Urethral disorder—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Headache—Vincristine—sarcoma	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Vomiting—Mitoxantrone—sarcoma	0.00136	0.00136	CcSEcCtD
Fosaprepitant—Rash—Mitoxantrone—sarcoma	0.00135	0.00135	CcSEcCtD
Fosaprepitant—Dermatitis—Mitoxantrone—sarcoma	0.00135	0.00135	CcSEcCtD
Fosaprepitant—Headache—Mitoxantrone—sarcoma	0.00134	0.00134	CcSEcCtD
Fosaprepitant—Erythema multiforme—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Fosaprepitant—Bradycardia—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Fosaprepitant—Eye disorder—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Hypersensitivity—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Tinnitus—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Nausea—Vincristine—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Flushing—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Cardiac disorder—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Fosaprepitant—Asthenia—Etoposide—sarcoma	0.00128	0.00128	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Fosaprepitant—Angiopathy—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Fosaprepitant—Urethral disorder—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Fosaprepitant—Nausea—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Fosaprepitant—Immune system disorder—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Fosaprepitant—Pruritus—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Fosaprepitant—Mental disorder—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Fosaprepitant—Erythema multiforme—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Fosaprepitant—Erythema—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Malnutrition—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Diarrhoea—Etoposide—sarcoma	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Eye disorder—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Tinnitus—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Flushing—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Cardiac disorder—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Flatulence—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Dysgeusia—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Fosaprepitant—Angiopathy—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Dizziness—Etoposide—sarcoma	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Muscle spasms—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Immune system disorder—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Fosaprepitant—Mental disorder—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Fosaprepitant—Vomiting—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Malnutrition—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Erythema—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Anaemia—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Rash—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Fosaprepitant—Dermatitis—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Fosaprepitant—Headache—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Fosaprepitant—Flatulence—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Fosaprepitant—Dysgeusia—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Fosaprepitant—Malaise—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Syncope—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Muscle spasms—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Palpitations—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Loss of consciousness—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Cough—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Nausea—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Fosaprepitant—Hypertension—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Fosaprepitant—Anaemia—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Fosaprepitant—Chest pain—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Fosaprepitant—Anxiety—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Fosaprepitant—Discomfort—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Malaise—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Dry mouth—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Syncope—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Palpitations—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Fosaprepitant—Oedema—Epirubicin—sarcoma	0.000999	0.000999	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Epirubicin—sarcoma	0.000999	0.000999	CcSEcCtD
Fosaprepitant—Loss of consciousness—Doxorubicin—sarcoma	0.000996	0.000996	CcSEcCtD
Fosaprepitant—Infection—Epirubicin—sarcoma	0.000993	0.000993	CcSEcCtD
Fosaprepitant—Cough—Doxorubicin—sarcoma	0.000988	0.000988	CcSEcCtD
Fosaprepitant—Shock—Epirubicin—sarcoma	0.000983	0.000983	CcSEcCtD
Fosaprepitant—Nervous system disorder—Epirubicin—sarcoma	0.00098	0.00098	CcSEcCtD
Fosaprepitant—Hypertension—Doxorubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Fosaprepitant—Skin disorder—Epirubicin—sarcoma	0.00097	0.00097	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Epirubicin—sarcoma	0.000966	0.000966	CcSEcCtD
Fosaprepitant—Chest pain—Doxorubicin—sarcoma	0.000964	0.000964	CcSEcCtD
Fosaprepitant—Anxiety—Doxorubicin—sarcoma	0.000961	0.000961	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000958	0.000958	CcSEcCtD
Fosaprepitant—Discomfort—Doxorubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Fosaprepitant—Dry mouth—Doxorubicin—sarcoma	0.000943	0.000943	CcSEcCtD
Fosaprepitant—Hypotension—Epirubicin—sarcoma	0.000934	0.000934	CcSEcCtD
Fosaprepitant—Oedema—Doxorubicin—sarcoma	0.000924	0.000924	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Doxorubicin—sarcoma	0.000924	0.000924	CcSEcCtD
Fosaprepitant—Infection—Doxorubicin—sarcoma	0.000918	0.000918	CcSEcCtD
Fosaprepitant—Shock—Doxorubicin—sarcoma	0.00091	0.00091	CcSEcCtD
Fosaprepitant—Nervous system disorder—Doxorubicin—sarcoma	0.000907	0.000907	CcSEcCtD
Fosaprepitant—Insomnia—Epirubicin—sarcoma	0.000904	0.000904	CcSEcCtD
Fosaprepitant—Skin disorder—Doxorubicin—sarcoma	0.000898	0.000898	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Doxorubicin—sarcoma	0.000894	0.000894	CcSEcCtD
Fosaprepitant—Dyspnoea—Epirubicin—sarcoma	0.000891	0.000891	CcSEcCtD
Fosaprepitant—Somnolence—Epirubicin—sarcoma	0.000888	0.000888	CcSEcCtD
Fosaprepitant—Dyspepsia—Epirubicin—sarcoma	0.000879	0.000879	CcSEcCtD
Fosaprepitant—Decreased appetite—Epirubicin—sarcoma	0.000869	0.000869	CcSEcCtD
Fosaprepitant—Hypotension—Doxorubicin—sarcoma	0.000864	0.000864	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Epirubicin—sarcoma	0.000863	0.000863	CcSEcCtD
Fosaprepitant—Fatigue—Epirubicin—sarcoma	0.000861	0.000861	CcSEcCtD
Fosaprepitant—Constipation—Epirubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Fosaprepitant—Pain—Epirubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Fosaprepitant—Insomnia—Doxorubicin—sarcoma	0.000836	0.000836	CcSEcCtD
Fosaprepitant—Dyspnoea—Doxorubicin—sarcoma	0.000824	0.000824	CcSEcCtD
Fosaprepitant—Feeling abnormal—Epirubicin—sarcoma	0.000823	0.000823	CcSEcCtD
Fosaprepitant—Somnolence—Doxorubicin—sarcoma	0.000822	0.000822	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Epirubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Fosaprepitant—Dyspepsia—Doxorubicin—sarcoma	0.000814	0.000814	CcSEcCtD
Fosaprepitant—Decreased appetite—Doxorubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000798	0.000798	CcSEcCtD
Fosaprepitant—Fatigue—Doxorubicin—sarcoma	0.000797	0.000797	CcSEcCtD
Fosaprepitant—Urticaria—Epirubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Fosaprepitant—Constipation—Doxorubicin—sarcoma	0.000791	0.000791	CcSEcCtD
Fosaprepitant—Pain—Doxorubicin—sarcoma	0.000791	0.000791	CcSEcCtD
Fosaprepitant—Abdominal pain—Epirubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Fosaprepitant—Body temperature increased—Epirubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Fosaprepitant—Feeling abnormal—Doxorubicin—sarcoma	0.000762	0.000762	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Doxorubicin—sarcoma	0.000756	0.000756	CcSEcCtD
Fosaprepitant—Hypersensitivity—Epirubicin—sarcoma	0.000736	0.000736	CcSEcCtD
Fosaprepitant—Urticaria—Doxorubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Fosaprepitant—Body temperature increased—Doxorubicin—sarcoma	0.000731	0.000731	CcSEcCtD
Fosaprepitant—Abdominal pain—Doxorubicin—sarcoma	0.000731	0.000731	CcSEcCtD
Fosaprepitant—Asthenia—Epirubicin—sarcoma	0.000717	0.000717	CcSEcCtD
Fosaprepitant—Pruritus—Epirubicin—sarcoma	0.000707	0.000707	CcSEcCtD
Fosaprepitant—Diarrhoea—Epirubicin—sarcoma	0.000684	0.000684	CcSEcCtD
Fosaprepitant—Hypersensitivity—Doxorubicin—sarcoma	0.000681	0.000681	CcSEcCtD
Fosaprepitant—Asthenia—Doxorubicin—sarcoma	0.000663	0.000663	CcSEcCtD
Fosaprepitant—Dizziness—Epirubicin—sarcoma	0.000661	0.000661	CcSEcCtD
Fosaprepitant—Pruritus—Doxorubicin—sarcoma	0.000654	0.000654	CcSEcCtD
Fosaprepitant—Vomiting—Epirubicin—sarcoma	0.000635	0.000635	CcSEcCtD
Fosaprepitant—Diarrhoea—Doxorubicin—sarcoma	0.000633	0.000633	CcSEcCtD
Fosaprepitant—Rash—Epirubicin—sarcoma	0.00063	0.00063	CcSEcCtD
Fosaprepitant—Dermatitis—Epirubicin—sarcoma	0.000629	0.000629	CcSEcCtD
Fosaprepitant—Headache—Epirubicin—sarcoma	0.000626	0.000626	CcSEcCtD
Fosaprepitant—Dizziness—Doxorubicin—sarcoma	0.000611	0.000611	CcSEcCtD
Fosaprepitant—Nausea—Epirubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Fosaprepitant—Vomiting—Doxorubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Fosaprepitant—Rash—Doxorubicin—sarcoma	0.000583	0.000583	CcSEcCtD
Fosaprepitant—Dermatitis—Doxorubicin—sarcoma	0.000582	0.000582	CcSEcCtD
Fosaprepitant—Headache—Doxorubicin—sarcoma	0.000579	0.000579	CcSEcCtD
Fosaprepitant—Nausea—Doxorubicin—sarcoma	0.000549	0.000549	CcSEcCtD
